Atlas Trials

Drug-drug Interaction Study of Vorasidenib With Bupropion, Repaglinide, Flurbiprofen, Omeprazole, Midazolam, and Rosuvastatin in Healthy Adult Participants

Clinical trial NCT07235748 · COMPLETED

Trial details

NCT number
NCT07235748
Sponsor
Institut de Recherches Internationales Servier (I.R.I.S.)
Status
COMPLETED
Phase
Phase 1
Study type
INTERVENTIONAL
Healthy Adult Participants
Start date
2025-10-07
Primary completion
2025-12-23
Enrollment
28

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.